Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial

Diabetes and Metabolism

Volumn 41, Issue 3, 2015, Pages 202-207

  Guerrero Romero, F ^a   Simental Mendia L E ^a   Hernandez Ronquillo G ^a   Rodriguez Moran M ^a  

^a Durango Institute of Technology   (Mexico)

Author keywords

Clinical trial; IFG; IGT; Magnesium; Prediabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MAGNESIUM CHLORIDE; PLACEBO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOMAGNESEMIA; IMPAIRED GLUCOSE TOLERANCE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINERAL SUPPLEMENTATION; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; DRUG EFFECTS; MAGNESIUM DEFICIENCY; METABOLISM; MIDDLE AGED; PREDIABETIC STATE;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MAGNESIUM CHLORIDE; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 84937638055     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.03.010     Document Type: Article

References (44)

1. Zimmet P.Z., Magliano D.J., Herman W.H., Shaw J.E. Diabetes: a 21st centurychallenge. Lancet Diabetes Endocrinol 2014, 2:56-64.
2. Phillips L.S., Ratner R.E., Buse J.B., Kahn S.E. We can change the natural history of type 2 diabetes. Diabetes Care 2014, 37:2668-2676.
3. Tabák A.G., Herder C., Rathmann W., Brunner E.J., Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379:2279-2290.
4. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
5. Lopez Martinez J., Sanchez Castilla M., Garcia de Lorenzo, Mateos A., Culebras Fernandez J.M. Magnesium: metabolism and requirements. Nutr Hosp 1997, 12:4-14.
6. Laughlin M.R., Thompson D. The regulatory role for magnesium in glycolytic flux of the human erythrocyte. J Biol Chem 1996, 271:28977-28983.
7. Paolisso G., Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997, 10:346-355.
8. Wells I.C. Evidence that the etiology of the syndrome containing type 2 diabetes mellitus results from abnormal magnesium metabolism. Can J Physiol Pharmacol 2008, 86:16-24.
9. Mooren F.C., Krüger K., Völker K., Golf S.W., Wadepuhl M., Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects-a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011, 13:281-284.
10. Guerrero-Romero F., Rodríguez-Morán M. Magnesiumimproves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. Eur J Clin Invest 2011, 41:405-410.
11. Hruby A., Meigs J.B., O'Donnell C.J., Jacques P.F., McKeown N.M. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes Care 2014, 37:419-427.
12. Hata A., Doi Y., Ninomiya T., Mukai N., Hirakawa Y., Hata J., et al. Magnesium intake decreases type 2diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study. Diabet Med 2013, 30:1487-1494.
13. Mejía-Rodríguez F., Shamah-Levy T., Villalpando S., García-Guerra A., Méndez-Gómez Humarán I. Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex 2013, 55:275-284.
14. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. The Expert Committee on the diagnosis and classification of diabetes mellitus: follow up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
16. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
17. Guerrero-Romero F., Tamez-Perez H.E., González-González G., Salinas-Martínez A.M., Montes-Villarreal J., Treviño-Ortiz J.H., et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004, 30:253-258.
18. Paolisso G., Scheen A., D'Onofrio F., Lefèbvre P. Magnesium and glucose homeostasis. Diabetologia 1990, 33:511-514.
19. Suárez A., Pulido N., Casla A., Casanova B., Arrieta F.J., Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995, 38:1262-1270.
20. Lima M., de L., Cruz T., Rodrigues L.E., Bomfim O., Melo J., et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009, 83:257-262.
21. Weglicki W.B. Hypomagnesemia-related inflammation in heart disease and diabetes. Cir Cir 2012, 80:209-210.
22. Weglicki W.B. Hypomagnesemia and inflammation: clinical and basic aspects. Annu Rev Nutr 2012, 32:55-71.
23. Lefebvre P.J., Paolisso G., Scheen A.J. Magnesium and glucose metabolism. Therapie 1994, 49:1-7.
24. Curry D.L., Joy R.M., Holley D.C., Bennett L. Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology 1997, 101:203-208.
25. Barbagallo M., Dominguez L.G., Galioto A., Ferlisi A., Cani C., Malfa L., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003, 24:39-52.
26. Chaudhary D.P., Sharma R., Bansal D.D. Implications of magnesium deficiency in type 2diabetes: a review. Biol Trace Elem Res 2010, 134:119-129.
27. Simental-Mendia L.E., Rodríguez-Morán M., Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res 2014, 45:325-330.
28. Simmons D., Joshi S., Shaw J. Hypomagnesaemia is associated with diabetes: notpre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010, 87:261-266.
29. Xu J., Xu W., Yao H., Sun W., Zhou Q., Cai L. Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast Population. PLoS ONE 2013, 8:e56750.
30. Liu Z.M., Ho S.C. The association of serum C-reactive protein, uric acid andmagnesium with insulin resistance in Chinese postmenopausal women with prediabetesor early untreated diabetes. Maturitas 2011, 70:176-181.
31. Guerrero-Romero F., Rascón-Pacheco R.A., Rodríguez-Morán M., de la Peña J.E., Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008, 38:389-396.
32. Paolisso G., Sgambato S., Gambardella A., Pizza G., Tesauro P., Varricchio M., et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992, 55:1161-1167.
33. Rodríguez-Morán M., Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res Rev 2011, 27:590-596.
34. Hadjistavri L.S., Sarafidis P.A., Georgianos P.I., Tziolas I.M., Aroditis C.P., Hitoglou-Makedou A., et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010, 16:CR307-CR312.
35. Lima de Souza E., Silva Mde L., Cruz T., Rodrigues L.E., Ladeia A.M., Bomfim O., et al. Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study. J Clin Med Res 2014, 6:456-462.
36. Ford E.S. Dietary magnesium intake in a National Sample of U.S. adults. J Nutr 2003, 133:2879-2882.
37. Karve A., Hayward R.A. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010, 33:2355-2359.
38. Guerrero-Romero F., Rodríguez-Morán M., Pérez-Fuentes R., Sánchez-Guillén M.C., González-Ortiz M., Martínez-Abundis E., et al. Prediabetes and its relationship with obesity in Mexican adults: the Mexican Diabetes Prevention (MexDiab) Study. Metab Syndr Relat Disord 2008, 6:15-23.
39. Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000individuals. Magnes Res 2001, 14:283-290.
40. Völzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011, 40:294-307.
41. Rodríguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014, 45:388-393.
42. Kishimoto Y., Tani M., Uto-Kondo H., Saita E., Iizuka M., Sone H., et al. Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br J Nutr 2010, 103:469-472.
43. Rasic-Milutinovic Z., Perunicic-Pekovic G., Jovanovic D., Gluvic Z., Cankovic-Kadijevic M. Association of blood pressure and metabolic syndrome components withmagnesium levels in drinking water in some Serbian municipalities. J Water Health 2012, 10:161-169.
44. Reinhart R., Marx J., Haas R., Desbiens N. Intracellular magnesium of mononuclear cells from venous blood of clinical healthy subjects. Clin Chim Acta 1987, 167:187-195.